JPS6429A - Antiviral agent - Google Patents

Antiviral agent

Info

Publication number
JPS6429A
JPS6429A JP62072553A JP7255387A JPS6429A JP S6429 A JPS6429 A JP S6429A JP 62072553 A JP62072553 A JP 62072553A JP 7255387 A JP7255387 A JP 7255387A JP S6429 A JPS6429 A JP S6429A
Authority
JP
Japan
Prior art keywords
ifn
human
produced
antiviral agent
units
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62072553A
Other languages
Japanese (ja)
Other versions
JP2550977B2 (en
JPH0129A (en
Inventor
Masaaki Takahashi
Koichi Yamanishi
Masami Moriyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP62072553A priority Critical patent/JP2550977B2/en
Publication of JPS6429A publication Critical patent/JPS6429A/en
Publication of JPH0129A publication Critical patent/JPH0129A/en
Application granted granted Critical
Publication of JP2550977B2 publication Critical patent/JP2550977B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PURPOSE: To provide an antiviral agent which contains interferon (IFN) as an active ingredient, thus being effective against a specific pathogen, especially huntan virus.
CONSTITUTION: The antiviral contains human IFN-α produced by human leukocytes, human IFN-β produced by human diplontic fibroblasts, IFN-α,β or γ produced by biotechnology. It is effective against huntan virus causing epidemic hemorrhagic fever or Korean hemorrhage fever. The dose is generally 500,000W3,500,000 units, preferably 800,000W1,200,000 units and within three times.
COPYRIGHT: (C)1989,JPO&Japio
JP62072553A 1987-02-13 1987-03-26 Antiviral agent Expired - Fee Related JP2550977B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62072553A JP2550977B2 (en) 1987-02-13 1987-03-26 Antiviral agent

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2971087 1987-02-13
JP62-29710 1987-02-13
JP62072553A JP2550977B2 (en) 1987-02-13 1987-03-26 Antiviral agent

Publications (3)

Publication Number Publication Date
JPS6429A true JPS6429A (en) 1989-01-05
JPH0129A JPH0129A (en) 1989-01-05
JP2550977B2 JP2550977B2 (en) 1996-11-06

Family

ID=26367946

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62072553A Expired - Fee Related JP2550977B2 (en) 1987-02-13 1987-03-26 Antiviral agent

Country Status (1)

Country Link
JP (1) JP2550977B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596004A (en) * 1983-09-14 1986-06-17 International Business Machines Corporation High speed memory with a multiplexed address bus
KR20030032605A (en) * 2001-10-19 2003-04-26 씨제이 주식회사 Protease obtained from Vibrio metschinikovii derivatives and thereof detergent compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596004A (en) * 1983-09-14 1986-06-17 International Business Machines Corporation High speed memory with a multiplexed address bus
KR20030032605A (en) * 2001-10-19 2003-04-26 씨제이 주식회사 Protease obtained from Vibrio metschinikovii derivatives and thereof detergent compositions

Also Published As

Publication number Publication date
JP2550977B2 (en) 1996-11-06

Similar Documents

Publication Publication Date Title
CA2081356A1 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n- acetyl neuraminic acid and their use as antiviral agents
ITMI931522A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION (HBV)
AU672825B2 (en) Vaccines inducing an immune response against viruses causing porcine respiratory and reproductive diseases
NZ329970A (en) Use of IFN-beta mutein derivatives for treating viral infections
IL85523A (en) Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it
IT8223795A0 (en) GAMMA), ITS VEHICLES OF POLYPEPTIDES CONTAINING THE EXPRESSION SEQUENCE, THEIR PROCEDURE OF INTERFERON AMINO ACIDS PREPARATION, HUMAN IMMUNE COMPOSITIONS (HUMAN INTERFERON PHARMACEUTICALS CONTAINING SUCH POLYPEPTIDES.
HUT54303A (en) Process for producing medicaments comprising cytokin, suitable for systemic treatment of preneoplastic lesions
CA2098021A1 (en) Composition Used as a Therapeutic Agent Against Chronic Viral Hepatic Diseases
IL91276A0 (en) Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases
NZ224189A (en) 6-substituted 2',3'-dideoxynucleosides and pharmaceutical compositions
IT1229562B (en) ANTIVIRAL AND IMMUNOSTIMULANT PHARMACEUTICAL COMPOSITIONS AND PROCEDURE FOR THEIR PREPARATION.
IL67978A0 (en) Human immune interferon,its preparation and purification and pharmaceutical compositions containing it
AU1226288A (en) Processes for the preparation of medicinal compositions, compositions obtained by these processes and use thereof for the preparation of medicines against viral hepatitis b and acquired immunodeficiency syndrome
DE3773295D1 (en) HOMOGENEOUS RECOMBINANT IMMUNE INTERFERON FRAGMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
IT1264332B1 (en) COMPOSITION FOR THE TREATMENT OF INFECTIONS AND DISEASES CAUSED BY THE HEPATITIS B VIRUS (HPV)
JPS6429A (en) Antiviral agent
FI922428A0 (en) NYA 2-AMINO-5-CYAN-1,4-DIHYDROPYRIDINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL.
ATE189262T1 (en) INTERFERON ALPHA/BETA BINDING PROTEIN, ITS PREPARATION AND ITS CONTAINING PHARMACEUTICAL COMPOSITIONS
IT8423517A0 (en) PHARMACEUTICAL COMPOSITION TO FIGHT VIRAL INFECTIONS, AND PROCEDURE FOR USE FOR VIRAL INFECTIONS.
GB2236478B (en) Antiviral medicinal composition
Hartshorn et al. Interferons.
EP0452360A4 (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
GR3006999T3 (en)
GR3017335T3 (en) Oligophosphates with antiviral activity.
IT1222142B (en) ANTIVIRAL PHARMACEUTICAL COMPOSITIONS

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees